title: Clinical Response to Pazopanib in a Patient With KDR-Mutated Metastatic Basal Cell Carcinoma.
authors.affiliation: DeBartolo Family Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
authors.forename: Todd C
authors.initials: TC
authors.lastname: Knepper
authors.affiliation: Melanoma and Cutaneous Oncology Program, The Angeles Clinic and Research Institute, Los Angeles, California.
authors.forename: Morganna L
authors.initials: ML
authors.lastname: Freeman
authors.affiliation: Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC.
authors.forename: Geoffrey T
authors.initials: GT
authors.lastname: Gibney
authors.affiliation: DeBartolo Family Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida4Department of Oncological Sciences, University of South Florida, Tampa, Florida.
authors.forename: Howard L
authors.initials: HL
authors.lastname: McLeod
authors.affiliation: Department of Oncological Sciences, University of South Florida, Tampa, Florida5Head and Neck and Endocrine Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
authors.forename: Jeffery S
authors.initials: JS
authors.lastname: Russell
mesh_terms: D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D004252:DNA Mutational Analysis; D004273:DNA, Neoplasm / Q000235:genetics*; D006801:Humans; D007191:Indazoles; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011743:Pyrimidines / Q000627:therapeutic use*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D013449:Sulfonamides / Q000627:therapeutic use*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000235:genetics* / Q000378:metabolism
chemical_list: D004273:DNA, Neoplasm; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib; C000588866:KDR protein, human; D040262:Receptors, Vascular Endothelial Growth Factor; D040301:Vascular Endothelial Growth Factor Receptor-2